Techniques, Safety, and Therapeutic Effect of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma
Abstract
Hepatocellular carcinoma (HCC) is the third most common cause of cancer-related deaths worldwide and the second most common cause in China. The rate of resection of HCC is limited to 20-30%. Therefore, various local ablative therapies such as radiofrequency ablation (RFA), percutaneous cryoablation (PC), microwave, and percutaneous ethanol injection therapy, which play an important role in the treatment of HCC, have been developed [1]. Recently, PC, a local ablative therapy, has been developed with several advantages (such as ability to produce larger and more precise zones of ablation) over RFA and other thermal ablation treatments. This review mainly focuses on the indications, techniques, patient management, safety, and efficacy associated with PC for patients with HCC.
[N A J Med Sci. 2016;9(2):66-70. DOI: 10.7156/najms.2016.0902066]
Keywords
References
European Association for the Study of the Liver; European Organisation for research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol. 2012;56:908-943.
Babaian RJ, Donnelly B, Bahn D, et al. Best practice statement on cryosurgery for the treatment of localized prostate cancer. J Urol. 2008;180:1993-2004.
Rubinsky B. Cryosurgery. Annu Rev Biomed Eng. 2000;2:157-187.
Erinjeri JP, Clark TW. Cryoablation: mechanism of action and devices. J Vasc Interv Radiol. 2010;21(8 Suppl):S187-S191.
Baust JG, Gage AA. The molecular basis of cryosurgery. BJU Int. 2005;95:1187-1191.
Rupp CC, Hoffmann NE, Schmidlin FR, et al. Cryosurgical changes in the porcine kidney: histologic analysis with thermal history correlation. Cryobiology. 2002;45(2):167-182.
Kimura M, Rabbani Z, Mouraviev V, et al. Morphology of hypoxia following cryoablation in a prostate cancer murine model: its relationship to necrosis, apoptosis and, microvessel density. Cryobiology. 2010;619:148-154.
Yang WL, Addona T, Nair DG, et al. Apoptosis induced by cryoinjury in human colorectal cancer cells is associated with mitochondrial dysfunction. Int J Cancer. 2003;103:360-369.
Baust JG, Gage AA, Clarke D, et al. Cryosurgery --a putative approach to molecular-based optimization. Cryobiology. 2004;48:190-204.
Klossner DP, Baust JM, VanBuskirk RG, et al. Cryoablative response of prostate cancer cells is influenced by androgen receptor expression. BJU Int. 2008;101:1310-1316.
Clarke DM, Robilotto AT, VanBuskirk RG, et al. Targeted induction of apoptosis via TRAIL and cryoablation: a novel strategy for the treatment of prostate cancer. Prostate Cancer Prostatic Dis. 2007; 10:175-184.
Weber S, Lee F. Cryoablation: History, Mechanism of Action, and Guidance Modalities. New York: Springer, 2005:250-265.
Clarke DM, Robilotto AT, Rhee E, et al. Cryoablation of renal cancer: variables involved in freezing-induced cell death. Technol Cancer Res Treat. 2007;6(2):69-79.
Woolley ML, Schulsinger DA, Durand DB, et al. Effect of freezing parameters (freeze cycle and thaw process) on tissue destruction following renal cryoablation. J Endourol. 2002;16:519-522.
Maccini M, Sehrt D, Pompeo A, et al. Biophysiologic considerations in cryoablation: a practical mechanistic molecular review. Int Braz J Urol. 2011;37:693-696.
Liu Z, Ahmed M, Weinstein Y, et al. Characterization of the RF ablation-induced‘oven effect’: the importance of background tissue thermal conductivity on tissue heating. Int J Hyperthermia. 2006; 22:327-342.
Orlacchio A, Bazzocchi G, Pastorelli D, et al. Percutaneous cryoablation of small hepatocellular carcinoma with US guidance and CT monitoring: initial experience. Cardiovasc Intervent Radiol. 2008;31:587-594.
Shimizu T, Sakuhara Y, Abo D, et al. Outcome of MR –guided percutaneous cryoablation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 2009;16:816-823.
Weber SM, Lee FT Jr, Warner TF, et al. Hepatic cryoablation: US monitoring of extent of necrosis in normal pig liver. Radiology. 1998;207:73-77.
Callstrom MR, Charboneau JW. Technologies for ablation of hepatocellular carcinoma. Gastroenterology. 2008;134:1831-1835.
Allaf ME, Varkarakis IM, Bhayani SB, et al. Pain control requirements for percutaneous ablation of renal tumors: cryoablation versus radiofrequency ablation-initial observations. Radiology. 2005; 237:366-370.
Shock SA, Laeseke PF, Sampson LA, et al. Hepatic hemorrhage caused by percutaneous tumor ablation: radiofrequency ablation versus cryoablation in a porcine model. Radiology. 2005;236:125-131.
Wang H, Littrup PJ, Duan Y, et al. Thoracic masses treated with percutaneous cryotherapy: initial experience with more than 200 procedures. Radiology. 2005;235:289-298.
Hinshaw JL, Lee FT Jr. Cryoablation for liver cancer. Tech Vasc Interv Radiol. 2007;10:47-57.
Müller-Schweinitzer E. Arterial smooth muscle function after prolonged exposure to a medium containing dimethyl sulfoxide (Me2SO) and storage at-196 degrees C. Cryobiology. 1994;31:330-335.
Yang YP, Wang CP, Lu YY, et al. Outcomes of ultrasound-guided percutaneous argon- helium cryoablation of hepatocellular carcinoma. J Hepatobiliary Pancreat Sci. 2012;19:674-684.
Rong GH, Bai WL, Dong Zheng, et al. Long-term Outcomes of Percutaneous Cryoablation for Patients with Hepatocellular Carcinoma within Milan Criteria. PLOS ONE. 2015;10:e23621.
Wang C, Wang H, Yang W, et al. A Multicenter Randomized Controlled Trial of Percutaneous Cryoablation Versus Radiofrequency Ablation Therapy in Patients with Hepatocellular Carcinoma. Hepatology. 2014 Oct 6. doi: 10.1002/hep.27548.
Joachim K. Seifert, M.D., David L. Morris, M.D., Ph.D. World Survey on the Complications of Hepatic and Prostate Cryotherapy. World J Surg. 1999;23(2):109-114.
Pearson AS, Izzo F, Fleming RY, et al.Intraoperative radiofrequency ablation or cryoablation for hepatic malignancies. Am J Surg. 1999;178:592-599.
Tait IS, Yong SM, Cuschieri SA. Laparoscopic in situ ablation of liver cancer with cryotherapy and radiofrequency ablation. Br J Surg. 2002;89:1613-1619.
Bilchik AJ, Wood TF, Allegra D, et al. Cryosurgical ablation and radiofrequency ablation for unresectable hepatic malignant neoplasms: a proposed algorithm. Arch Surg. 2000;135:657-662;
Rong G, Bai W, Dong Z, et al. Cryotherapy for cirrhosis-based hepatocellular carcinoma: a single center experience from 1595 treated cases. Front Med. 2015;9:63-71.
Wang CP, Wang H, Qu JH, et al. Tumour seeding after percutaneous cryoablation for hepatocellular carcinoma. World J Gastroenterol. 2012;18:6587-6596.
Wang C, Lu Y, Chen Y, et al. Prognostic factors and recurrence of hepatitis B -related hepatocellular carcinoma after argon –helium cryoablation: a prospective study. Clin Exp Metastasis. 2009;26:839-848.
Kim YS, Lim HK, Rhim H, Lee MW, Choi D, Lee WJ, et al. Ten-year outcomes of percutaneous radiofrequency ablation as first-line therapy of early hepatocellular carcinoma: analysis of prognostic factors. J Hepatol. 2013;58:89-97.
Rossi S, Ravetta V, Rosa L, Ghittoni G, Viera FT, Garbagnati F, et al. Repeated radiofrequency ablation for management of patients with cirrhosis with small hepatocellular carcinomas: A long-term cohort study. Hepatology. 2011;53:136-147.
Shiina S, Tateishi R, Arano T, Uchino K, Enooku K, Nakagawa H, et al. Radiofrequency ablation for hepatocellular carcinoma: 10-year outcome and prognostic factors. Am J Gastroenterol. 2011;107:569-577.
Dunne RM, Shyn PB, Sung JC, et al. Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: A comparison of the safety of cryoablation and radiofrequency ablation. Eur J Radiol. 2014;83:632-638.
Shigenori E, Taizo H, Minoru T, et al. Cryoablation Provides Superior Local Control of Primary Hepatocellular Carcinomas of > 2 cm Compared with Radiofrequency Ablation and Microwave Coagulation Therapy: An Underestimated Tool in the Toolbox. Ann Surg Oncol. 2015;22:1294-1300.
Yang YP, Qu JH, Chang XJ, et al. High intratumoral metastasis-associated in colon cancer-1 expression predicts poor outcomes of cryoablation therapy for advanced hepatocellular carcinoma. J Transl Med. 2013;11:41-55.
Zhou L, Fu JL, Lu YY, et al. Regulatory T cells are associated with post-cryoablation prognosis in patients with hepatitis B virus-related hepatocellular carcinoma. J Gastroenterol. 2010;45:968-978.
Zeng Z, Shi F, Zhou L, et al. Upregulation of circulating PD-L1/PD-1 is associated with poor post-cryoablation prognosis in patients with HBV-related hepatocellular carcinoma. PLOS ONE. 2011;6:e23621.
Refbacks
- There are currently no refbacks.